Log In
BCIQ
Print this Print this
 

AD-114

  Manage Alerts
Collapse Summary General Information
Company AdAlta Ltd.
DescriptionHuman single domain antibody that antagonizes CXC chemokine receptor 4 (CXCR4; NPY3R)
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationPulmonary fibrosis
Indication DetailsTreat idiopathic pulmonary fibrosis (IPF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today